Advanced search
Publication Cover
Gut Microbes Volume 14, 2022 - Issue 1
Submit an article Journal homepage
4,416
Views
23
CrossRef citations to date
0
Altmetric
Research Paper

Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice

Shi-Long Zhanga Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China;b Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, ChinaORCID Iconhttps://orcid.org/0000-0003-3095-4246View further author information
ORCID Icon,
Bing Hana Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China;b Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, ChinaView further author information
,
Yu-Qin Maoa Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China;b Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, ChinaView further author information
,
Zheng-Yan Zhanga Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China;b Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, ChinaView further author information
,
Zhan-Ming Lia Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China;b Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, ChinaView further author information
,
Chao-Yue Konga Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China;b Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, ChinaView further author information
,
You Wua Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China;b Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, ChinaView further author information
,
Guo-Qiang Chenc State Key Laboratory of Oncogenes and Related Genes, and Chinese Academy of Medical Sciences Research Unit (NO.2019RU043), Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Li-Shun Wanga Center for Traditional Chinese Medicine and Gut Microbiota, Minhang Hospital, Fudan University, Shanghai, China;b Institute of Fudan-Minhang Academic Health System, Minhang Hospital, Fudan University, Shanghai, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2046246 | Received 25 Dec 2021, Accepted 09 Feb 2022, Published online: 08 Mar 2022

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xinhai Zhu, Ke Li, Guichao Liu, Ruan Wu, Yan Zhang, Siying Wang, Meng Xu, Ligong Lu & Peng Li. (2023) Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell. Gut Microbes 15:2.
Read now

Articles from other publishers (22)

Jiating Huang, Yuqin Mao & Lishun Wang. (2024) The crosstalk of intratumor bacteria and the tumor. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Qi'an Wang, Bensheng Jiang, Min Wei, Yao He, Yujie Wang, Qimeng Zhang, Hua Wei & Xueying Tao. (2024) Antitumor effect of exopolysaccharide from Lactiplantibacillus plantarum WLPL09 on melanoma mice via regulating immunity and gut microbiota. International Journal of Biological Macromolecules 254, pages 127624.
Crossref
Yao Jiang, Dingjiacheng Jia, Yong Sun, Ning Ding & Liangjing Wang. (2023) Microbiota: A key factor affecting and regulating the efficacy of immunotherapy. Clinical and Translational Medicine 13:12.
Crossref
Maria Rescigno. (2023) Training the microbiota to increase immune checkpoint blockade and to reduce toxicity. European Journal of Immunology 53:11.
Crossref
Ciliang Guo, Lingkai Kong, Lingjun Xiao, Kua Liu, Huawei Cui, Qilei Xin, Xiaosong Gu, Chunping Jiang & Junhua Wu. (2023) The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies. Cell & Bioscience 13:1.
Crossref
Zhan-Ming Li, Chao-Yue Kong, Yu-Qin Mao, Hui-Ling Chen, Shi-Long Zhang, Jia-Ting Huang, Jin-Qing Yao, Pei-Ran Cai, Nuo Xie, Bing Han & Li-Shun Wang. (2023) Host ALDH2 deficiency aggravates nonalcoholic steatohepatitis through gut-liver axis. Pharmacological Research 196, pages 106902.
Crossref
Valentina Ferrari, Antonino Lo Cascio, Alessia Melacarne, Nina Tanasković, Alessandro M. Mozzarelli, Luca Tiraboschi, Michela Lizier, Marta Salvi, Daniele Braga, Francesca Algieri, Giuseppe Penna & Maria Rescigno. (2023) Sensitizing cancer cells to immune checkpoint inhibitors by microbiota-mediated upregulation of HLA class I. Cancer Cell 41:10, pages 1717-1730.e4.
Crossref
Yu-Pei Zhuang, Hong-Li Zhou, Hai-Bin Chen, Ming-Yue Zheng, Yu-Wei Liang, Yu-Tian Gu, Wen-Ting Li, Wen-Li Qiu & Hong-Guang Zhou. (2023) Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application. Biomedicine & Pharmacotherapy 165, pages 115040.
Crossref
Teng Ma, Xin Shen, Xuan Shi, Hafiz Arbab Sakandar, Keyu Quan, Yalin Li, Hao Jin, Lai-Yu Kwok, Heping Zhang & Zhihong Sun. (2023) Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review. Trends in Food Science & Technology 138, pages 178-198.
Crossref
Xiangdong Yan, Liuhui Bai, Ping Qi, Jin Lv, Xiaojing Song & Lei Zhang. (2023) Potential Effects of Regulating Intestinal Flora on Immunotherapy for Liver Cancer. International Journal of Molecular Sciences 24:14, pages 11387.
Crossref
Chi Chun Wong & Jun Yu. (2023) Gut microbiota in colorectal cancer development and therapy. Nature Reviews Clinical Oncology 20:7, pages 429-452.
Crossref
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, Lei Lei, Wei-Han Zhang, Kai Liu, Xiao-Long Chen, Damian Kołat, Kun Yang & Jian-Kun Hu. (2023) Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Signal Transduction and Targeted Therapy 8:1.
Crossref
Zhan‐Ming Li, Chao‐Yue Kong, Yu‐Qin Mao, Jia‐Ting Huang, Hui‐Ling Chen, Bing Han & Li‐Shun Wang. (2023) Ampicillin exacerbates acetaminophen‐induced acute liver injury by inducing intestinal microbiota imbalance and butyrate reduction. Liver International 43:4, pages 865-877.
Crossref
Zhengyan Zhang, Huiling Chen, Jiating Huang, Shilong Zhang, Zhanming Li, Chaoyue Kong, Yuqin Mao & Bing Han. (2023) Early Administration of Vancomycin Inhibits Pulmonary Embolism by Remodeling Gut Microbiota. Journal of Personalized Medicine 13:3, pages 537.
Crossref
Han Sang Kim, Chang Gon Kim, Won Kyu Kim, Kyung-A Kim, Jinseon Yoo, Byung Soh Min, Soonmyung Paik, Sang Joon Shin, Hyukmin Lee, Kyungwon Lee, Hoguen Kim, Eui-Cheol Shin, Tae-Min Kim & Joong Bae Ahn. (2023) Fusobacterium nucleatum induces a tumor microenvironment with diminished adaptive immunity against colorectal cancers. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Connor Campbell, Mrunmayee R. Kandalgaonkar, Rachel M. Golonka, Beng San Yeoh, Matam Vijay-Kumar & Piu Saha. (2023) Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy. Biomedicines 11:2, pages 294.
Crossref
Man Wang, Lei Zhang, Wenguang Chang & Yuan Zhang. (2023) The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes. Frontiers in Immunology 13.
Crossref
Jinglong Huang, Caifeng Gong & Aiping Zhou. (2023) Modulation of gut microbiota: a novel approach to enhancing the effects of immune checkpoint inhibitors. Therapeutic Advances in Medical Oncology 15.
Crossref
Sunny H. Wong. 2023. Microbiome in Gastrointestinal Cancer. Microbiome in Gastrointestinal Cancer 251 267 .
Cong Xia, Yantao Cai, Shuangyi Ren & Chenglai Xia. (2022) Role of microbes in colorectal cancer therapy: Cross-talk between the microbiome and tumor microenvironment. Frontiers in Pharmacology 13.
Crossref
Jie Fang, Chen-Huan Yu, Xue-Jian Li, Jin-Mei Yao, Zheng-Yu Fang, Soo-Hyun Yoon & Wen-Ying Yu. (2022) Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Lu Lu, Jiahuan Dong, Yujing Liu, Yufan Qian, Guangtao Zhang, Wenjun Zhou, Aiguang Zhao, Guang Ji & Hanchen Xu. (2022) New insights into natural products that target the gut microbiota: Effects on the prevention and treatment of colorectal cancer. Frontiers in Pharmacology 13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.